Discovery of ZSL-M028: A Potent, Selective and Orally Available Quinazoline-Based PLK4 Inhibitor TargetingTRIM37-Amplified Neuroblastoma

发表于 2026-7-21 16:53:57

期刊：Journal of Medicinal Chemistry

文献作者：Nian Liu; Zehui Qi; Wenqiang Sun; Minghui Tong; Xuan Shi; Han Wang; Shuyi Mu; Ningyuan Hu; Zirui Luo; Cunzheng Fan; Haoyu Zhang; Zixuan Gao; Yin Sun; Dongmei Zhao; Maosheng Cheng

出版日期：--

DOI号：10.1021/acs.jmedchem.6c01348

下载链接：https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6c01348

文献链接：https://doi.org/10.1021/acs.jmedchem.6c01348

当前文献来源于 American Chemical Society (ACS)。

备注信息：

发表于 2026-7-21 16:53:58

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[ACS] Discovery of ZSL-M028: A Potent, Selective and Orally Available Quinazoline-Based PLK4 Inhibitor TargetingTRIM37-Amplified Neuroblastoma

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ACS] Discovery of ZSL-M028: A Potent, Selective and Orally Available Quinazoline-Based PLK4 Inhibitor TargetingTRIM37-Amplified Neuroblastoma 一键复制